Pediatric atopic dermatitis: biomarker advances in severity, persistence, and non-invasive monitoring
Frontiers in Pediatrics · 18.08.2026 · 14
DOI: 10.3389/fped.2026.1902799 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pediatrics, online erschienen am 18.08.2026. Verfasst von Zhuoyuan Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Guizhou Medical University, Guiyang, China. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atopic dermatitis (AD) in children differs immunologically and in barrier characteristics from adult AD, yet current severity assessment still relies heavily on clinical scoring systems with inherent subjectivity. This review summarizes advances in biomarkers associated with disease severity and persistence, as well as non-invasive detection techniques and targeted therapies. TARC/CCL17, periostin, total IgE, and eosinophil counts show consistent utility in grading severity, whereas FLG loss-of-function mutations, VEGF, S100A8/A9, and early skin barrier indicators are promising predictors of disease persistence and atopic march progression. Tape stripping and sebum RNA analysis enable safe, repeated monitoring in children. Despite these advances, most biomarkers still lack pediatric-specific cut-offs and large-scale validation. Future efforts should focus on establishing multi-marker panels, pediatric reference intervals, and machine learning models for endotype classification. Incorporating these tools into routine practice would facilitate early risk stratification, precise targeted treatment selection, and ultimately more personalized management of pediatric AD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Clinical Medicine, Guizhou Medical University, Guiyang, China.
- Department of Dermatology, Children's Hospital of Shanxi Province, Taiyuan, China.
Zitieren
APA
Li, Z., & Li, Y. (2026). Pediatric atopic dermatitis: biomarker advances in severity, persistence, and non-invasive monitoring. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1902799
Vancouver
Li Z, Li Y. Pediatric atopic dermatitis: biomarker advances in severity, persistence, and non-invasive monitoring. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1902799
BibTeX
@article{Li2026,
author = {Li, Zhuoyuan and Li, Yuanjun},
title = {Pediatric atopic dermatitis: biomarker advances in severity, persistence, and non-invasive monitoring},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.1902799}
}
EUVIMED